Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
02/2009
02/12/2009CA2695864A1 Gamma secretase modulators
02/12/2009CA2695405A1 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
02/12/2009CA2693997A1 Viral polymerase inhibitors
02/12/2009CA2693495A1 Viral polymerase inhibitors
02/11/2009EP2021339A1 Rosiglitazone hydrochloride hemihydrate
02/11/2009EP2021338A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
02/11/2009EP2021335A1 Heterocyclic compounds as inhibitors of c-fms kinase
02/11/2009EP2021327A2 Antidiabetic bicyclic compounds
02/11/2009EP2021324A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
02/11/2009EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
02/11/2009CN101365698A 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
02/11/2009CN101365697A Tetomilast polymorphs
02/11/2009CN101365696A Compounds and compositions as modulators of steroid hormone nuclear receptors
02/11/2009CN101365695A Quinazoline derivatives as anticancer agents
02/11/2009CN101365694A Heterocycle-substituted 3-alkyl azetidine derivatives
02/11/2009CN101365690A Biphenyl derivatives as modulators of voltage gated ion channels
02/11/2009CN101365689A 1,3-oxazolidin-2-one derivatives useful as cetp inhibitors
02/11/2009CN101365686A Heterocyclic derivatives as modulators of ion channels
02/11/2009CN101365685A 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the TRPV1 receptor
02/11/2009CN101362731A Heterocyclic compounds and methods of use
02/10/2009US7488824 Process for the production of substituted nicotinic acid esters
02/10/2009US7488823 4-anilino quinazolines substituted with a N'-cyanoguanidinoalkyl group; antiproliferative, anticancer, antiinflammatory
02/10/2009US7488822 Cyclocarbamate derivatives as progesterone receptor modulators
02/10/2009US7488811 Lacking cladinose in position 3, de(N-methyl)-descladinosyl-9-dihydro-erythromycin A; free of antibiotic properties; diseases related to an impaired cellular functionality of neutrophils, for instance rheumatoid arthritis, reperfusion ischaemia injury, septic shock, atherosclerosis
02/10/2009US7488745 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
02/10/2009US7488742 Therapy for thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
02/10/2009US7488729 Polymorphic forms of ziprasidone and its hydrochloride salt and process for preparation thereof
02/10/2009US7488727 Thiazole compounds useful as inhibitors of protein kinase
02/10/2009CA2189044C Acylated aminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
02/05/2009WO2009017951A2 Pesticides and uses thereof
02/05/2009WO2009017822A2 Pi3 kinase modulators and methods of use
02/05/2009WO2009017671A1 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
02/05/2009WO2009017664A1 CYCLIC INHIBITORS OF 11β-HYDROXYSTERIOD DEHYDROGENASE 1
02/05/2009WO2009017346A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same
02/05/2009WO2009017219A1 Inhibitor of binding of s1p1
02/05/2009WO2009016564A2 2-aza-bicyclo[3.3.0]octane derivatives
02/05/2009WO2009016560A2 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
02/05/2009WO2009016222A1 Fungicide n-5-membered fused heteroaryl-methylene-n-cycloalkyl-carboxamide derivatives
02/05/2009WO2009016221A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
02/05/2009WO2009016219A1 Fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives
02/05/2009WO2009015897A1 Novel heterocyclic compounds as mglu5 antagonists
02/05/2009WO2009015877A1 Novel herbicides
02/05/2009WO2009015812A2 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile
02/05/2009WO2009015811A1 Dipeptoid prodrugs and the use thereof
02/05/2009WO2008124703A3 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
02/05/2009WO2008028032A4 Therapeutic substituted hydantoins and related compounds
02/05/2009WO2007003521A3 Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
02/05/2009US20090036467 Alkylsulfonyl-substituted thiazolide compounds
02/05/2009US20090036457 Utilities of olefin derivatives
02/05/2009US20090036448 Pyrimidine derivatives and methods of treatment related to the use thereof
02/05/2009US20090036447 Compounds, Compositions and Methods
02/05/2009US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists
02/05/2009US20090036438 Five-membered heterocycles useful as serine protease inhibitors
02/05/2009US20090036436 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
02/05/2009US20090036434 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
02/05/2009US20090036433 Heterocyclic Compounds, their Preparation and their Use as Antibacterials
02/05/2009US20090035810 Modified carbocyanine dyes and their conjugates
02/05/2009US20090035809 Modified Carbocyanine Dyes and Their Conjugates
02/05/2009US20090035313 Compounds
02/05/2009US20090035309 Substituted Benzazoles and Methods of Their Use as Inhibitors of RAF Kinase
02/05/2009DE102007036076A1 Dipeptoid-Produgs und ihre Verwendung Dipeptoid prodrugs and their use
02/05/2009DE102007036075A1 Prodrugs und ihre Verwendung Prodrugs and their use
02/05/2009CA2698170A1 Prodrugs of 2-amino-6- ( { [2- (4-chlorphenyl) -1, 3-thiaz0l-4-yl] methyl}thio) -4- [4- ( 2 -hydroxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile
02/05/2009CA2697168A1 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
02/05/2009CA2697147A1 Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
02/05/2009CA2694639A1 Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same
02/05/2009CA2694359A1 Novel heterocyclic compounds as mglu5 antagonists
02/05/2009CA2694136A1 Pi3 kinase modulators and methods of use
02/05/2009CA2693820A1 2-aza-bicyclo[3.3.0]octane derivatives
02/05/2009CA2693817A1 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
02/05/2009CA2693190A1 Novel herbicides
02/05/2009CA2692696A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
02/05/2009CA2684889A1 Pesticides and uses thereof
02/04/2009EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity
02/04/2009EP2020232A1 N-(1-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
02/04/2009EP2019829A1 N- ( 2-thiazolyl) -amide derivatives as gsk-3 inhibitors
02/04/2009EP2019828A1 N- (2-thiazolyl) -amide derivatives as gsk-3 inhibitors
02/04/2009EP2019827A1 Integrase inhibitors 3
02/04/2009EP2019824A2 Benzamide glucokinase activators
02/04/2009EP2019820A1 Therapeutic pyrrolidine compounds
02/04/2009EP1601653B1 Process for the production of substituted nicotinic acid esters
02/04/2009EP1551818B1 Thiadiazoledioxides and thiadiazoleoxides as cxc- and cc-chemokine receptor ligands
02/04/2009EP0821589B1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
02/04/2009CN101360743A Polycyclic 1, 2, 3, 4 -tetrahydro- isoquinoline derivatives and compositions comprising them as ppar modulators
02/04/2009CN101360740A Aminopyrimidines useful as kinase inhibitors
02/04/2009CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
02/04/2009CN100457742C Biaryl heterocyclic compounds and methods of making and using the same
02/04/2009CN100457731C Benzamide modulators of metabotropic glutamate receptors
02/04/2009CN100457728C Tyrosine kinase inhibitors
02/03/2009US7485733 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle
02/03/2009US7485724 2,4-pyrimidinediamine compounds and their uses
02/03/2009US7485706 Has a domain that preferentially binds to aggregations comprising at least two monomeric proteins linked to a second domain that recruits the aggregation modifying protein; neurotoxicity; neurodegenerative diseases
02/03/2009US7485655 2-Aminothiazole allosteric enhancers of A1 adenosine receptors
02/03/2009US7485652 Indolyl derivatives as liver-X-receptor (LXR) modulators
02/03/2009US7485643 Bicyclic inhibitors of MEK and methods of use thereof
02/03/2009US7485625 Inhibitors of hepatitis C virus NS3/NS4a serine protease
02/03/2009CA2478146C Spiro and dispiro 1,2,4-trioxolane antimalarials
02/03/2009CA2382435C Novel herbicidally active phenyl-substituted heterocycles
02/03/2009CA2314607C Use of ppar-.gamma. activators in dermatology
01/2009
01/29/2009WO2009015254A1 Triazine kinase inhibitors